Market Place
Sourcing Support
Kymera Therapeutics Announces Sanofi IRAK4 Collaboration Update
25 Jun 2025 //
PRESS RELEASE
Sarclisa Recommended for EU Approval by CHMP for Myeloma
24 Jun 2025 //
PRESS RELEASE
Sanofi Signs €545M Deal to Explore Formation’s JAK/SYK Inhibitor
24 Jun 2025 //
PR NEWSWIRE
Dupixent US Approval For Bullous Pemphigoid Treatment
21 Jun 2025 //
PRESS RELEASE
Abu Dhabi Health Dept. and Sanofi Partner for Global Vaccines
18 Jun 2025 //
PR NEWSWIRE
Dupixent Beats Xolair in Ph4 Nasal Polyp Study at EAACI 2025
15 Jun 2025 //
PRESS RELEASE
EQT Life Sciences Co-Leads $135M Series B Financing for SpliceBio
11 Jun 2025 //
PR NEWSWIRE
Sanofi: Voting rights and shares info - May 2025
09 Jun 2025 //
GLOBENEWSWIRE
Sanofi Ships Beyfortus Early Ahead of 2025–2026 RSV Season
09 Jun 2025 //
PRESS RELEASE
Sanofi Launches 2025 Global Stock Purchase Plan
05 Jun 2025 //
PRESS RELEASE
ASCO: Sarclisa data support subcutaneous administration
03 Jun 2025 //
PRESS RELEASE
Rilzabrutinib Grants Orphan Designation for Sickle Cell Disease
03 Jun 2025 //
PRESS RELEASE
Sanofi to buy US biopharma group Blueprint for over $9 billion
03 Jun 2025 //
PRESS RELEASE
Recludix Names STAT6 Inhibitor Candidate Under Sanofi Deal
02 Jun 2025 //
GLOBENEWSWIRE
Sanofi Extends License for Nurix`s STAT6 program
02 Jun 2025 //
PRESS RELEASE
Study Shows Beyfortus Advantage Over Maternal RSV Vaccine
29 May 2025 //
GLOBENEWSWIRE
Itepekimab meets primary endpoint in COPD phase 3 study
29 May 2025 //
PRESS RELEASE
FDA Approves Use of Sanofi`s Meningococcal Vaccine in Infants
28 May 2025 //
PRESS RELEASE
Sanofi Exploring Vaccine Production in Vietnam with Local Partner
28 May 2025 //
REUTERS
Sanofi slammed for giving Olympics tickets to UK Patients
27 May 2025 //
FIERCE PHARMA
C4X Discovery receives latest milestone payment from Sanofi
27 May 2025 //
GLOBENEWSWIRE
Sanofi Completes Acquisition of DR-0201
27 May 2025 //
PRESS RELEASE
Sanofi cuts ribbon at `flagship` US office facility
23 May 2025 //
PRESS RELEASE
Sanofi to Acquire Vigil Neuroscience in $470M Deal
22 May 2025 //
PRESS RELEASE
Viz.ai Collaborates With Sanofi and Regeneron on COPD Care
21 May 2025 //
PRESS RELEASE
FDA approves Novavax COVID vaccine with new conditions
20 May 2025 //
PRESS RELEASE
Sanofi India posts 27% growth in operating profits in Q1 2025
16 May 2025 //
INDPHARMAPOST
Sanofi: Total Voting Rights and Shares - April 2025
15 May 2025 //
GLOBENEWSWIRE
Sanofi to spend $20B in US on R&D, manufacturing through 2030
15 May 2025 //
PR NEWSWIRE
Sanofi axes IGM pact, sparking 80% layoffs at the biotech
09 May 2025 //
FIERCE BIOTECH
Sanofi-Aventis`s Tzield Receives Approval in Canada
05 May 2025 //
HEALTH CANADA
Sanofi: Voting rights and shares info - March 2025
02 May 2025 //
GLOBENEWSWIRE
Sanofi sells controlling stake of consumer health unit for €10B
01 May 2025 //
PRESS RELEASE
Annual General Meeting of April 30, 2025
30 Apr 2025 //
PRESS RELEASE
Sanofi, McLaren Racing, United Autosports Raise Meningitis Awareness
29 Apr 2025 //
PRESS RELEASE
Dr Reddy`s to introduce Sanofi`s novel drug in India
29 Apr 2025 //
PRESS RELEASE
Sanofi`s profit boosted by Dupixent and newer drugs; forecast
25 Apr 2025 //
REUTERS
Sobi, Sanofi`s Foundation extend partnership with WFH Humanitaria
25 Apr 2025 //
PRESS RELEASE
Sanofi: strong Q1 performance and 2025 guidance confirmed
25 Apr 2025 //
PRESS RELEASE
Sanofi`s profit boosted by Dupixent and newer drugs; forecast
24 Apr 2025 //
REUTERS
Sanofi off to a promising start in launch of Dupixent for COPD
24 Apr 2025 //
FIERCE PHARMA
Innate Pharma Announces 15M Investment by Sanofi
24 Apr 2025 //
BUSINESSWIRE
Sanofi hands cancer drug to Innate as it pivots R&D pact focus
24 Apr 2025 //
PRESS RELEASE
Novartis & Sanofi CEOs say EU should raise drug prices of tariffs
23 Apr 2025 //
REUTERS
Sanofi-Regeneron`s Dupixent gets FDA`s nod for skin condition
21 Apr 2025 //
PRESS RELEASE
Sanofi pens $1.8B deal for 2 autoimmune, immunology bispecifics
17 Apr 2025 //
FIERCE BIOTECH
Sanofi signs up Chrissy Teigen for diabetes screening campaign
15 Apr 2025 //
FIERCE PHARMA
Sanofi`s Respiratory Pipeline Advances with New Asthma Data
15 Apr 2025 //
PRESS RELEASE
Sanofi India MD Rodolfo Hrosz to step down on April 30
11 Apr 2025 //
INDPHARMAPOST
Tolebrutinib phase 3 data in NEJM show benefit in MS disability
08 Apr 2025 //
PRESS RELEASE
Rilzabrutinib granted orphan drug designation in US for 2 diseases
04 Apr 2025 //
PRESS RELEASE
Sanofi: Total voting rights and shares - Feb 2025
03 Apr 2025 //
GLOBENEWSWIRE
Sanofi pays Nurix $15M upfront for autoimmune degrader
03 Apr 2025 //
PRESS RELEASE
Sanofi poaches GSK’s head of development for R&D bet
01 Apr 2025 //
ENDPTS
US FDA approves Sanofi`s bleeding disorder therapy
29 Mar 2025 //
PRESS RELEASE
Sanofi`s mRNA vaccine for chlamydia gains USFDA fast track
28 Mar 2025 //
EXPRESSPHARMA
Dupixent approved as first biologic for COPD in Japan
28 Mar 2025 //
GLOBENEWSWIRE
Sanofi`s Altuviiio Receives Approval in Canada
26 Mar 2025 //
HEALTH CANADA
Chlamydia vaccine candidate granted fast track designation by FDA
26 Mar 2025 //
GLOBENEWSWIRE
Tolebrutinib Submission Accepted In US For Multiple Sclerosis
25 Mar 2025 //
PRESS RELEASE
